Bladder cancer
Brain cancer
Breast cancer
Cancer of the spleen
Intestinal cancer
Liver cancer
Lung cancer
Oropharynx cancer
Peritoneal carcinosis
Pleura tumor
Prostate tumor
Skin cancer
Stomach cancer
Tumor of the pancreas
Tumors of the limbs
LATEST VIDEO OF DR SIMONCINI
BICARBONATE INHIBITS SPONTANEOUS METASTASES
A NEW YEAR HAS COME
DR. APSLEY ON RSBELL RADIO
THE GAG OF EXPERIMENTATION
THE NOISY RESEARCHES ON CANCER
AUSSIE ONCOLOGISTS CRITICIZE CHEMOTHERAPY
DEPENDING ON ADVERTISORS/FINANCERS
WHY NOT TRUST HEALTH MARKET
EMAILS TO DR. SIMONCINI
ADVERSE HEALTH EFFECTS INDOOR MOULDS
SCIENCE OF THE ORTHODOX CANCER TREATMENTS
Dr. Tullio Simoncini is a roman doctor specialising in oncology, diabetology and in metabolic disorders.
Doses of sodium bicarbonate at 5%, as indicated in the Simoncini treatment are innocuous. In fact they have been used without any problems for over 30 years
breast cancer, bone cancer, prostate cancer, liver cancer, pancreas cancer
But then... if a law exists, ...if even the Court of Cassation has spoken in favour of the therapeutic...
"Sodium bicarbonate, unlike other anti-fungal remedies to which the fungus can become immune, is extremely diffusible and retains its ability to penetrate the tumor, due to the speed at which the sodium bicarbonate disintegrates the tumor. This speed makes fungi's adaptability impossible, rendering it defenseless.".
Based on years of scientific and clinical research, at the centre of every cancer tumour is a common fungus, Candida albicans. The good news is that it can be treated with a powerful antifungal agent that's inexpensive and readily available.
Colon cancer
Prostate adenocarcinoma
Prostate carcinoma
Terminal carcinoma of uterine cervix
Peritoneal carcinosis in adenocarcinoma of endom
Non Hodgkin Lymphoma
Cerebral metastasis in diffused melanoma
Right eye melanoma
Ewing's Sarcoma
Lung cancer
Relapsing bladder neoplasm
Hepatic metastase of cholangiocarcinoma
Medullar metastatic compression
Hepatic carcinoma
Hepatic carcinoma with pulmonary metastasis
Hepatic carcinoma 2